Bright Minds Biosciences Inc. (DRUG) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Bright Minds Biosciences Inc. (DRUG) quarterly balance sheet — complete assets, liabilities & equity history

Quarterly statement

DRUG Balance Sheet

Bright Minds Biosciences Inc. (DRUG) balance sheet — 7-year assets, liabilities & shareholders' equity history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Total Current Assets	310.79M	312.07M	90.79M	84.31M	52.37M	56.31M	58.22M	5.99M	6.27M	6.5M	6.84M	6.81M	8.38M	9.88M	11.43M	11.95M	8.82M	11.76M	15.41M	20.04M
Cash & Short-Term Investments	308.33M	309.47M	89.05M	82.91M	51.39M	55.68M	57.9M	5.72M	6.19M	5.93M	6.76M	6.75M	8.13M	9.67M	11.21M	11.63M	8.64M	11.47M	15.12M	19.76M
Cash Only	308.16M	309.3M	89.05M	82.91M	51.39M	55.68M	57.9M	5.72M	6.19M	5.93M	6.76M	6.75M	8.13M	9.67M	11.21M	11.63M	8.64M	11.47M	15.12M	19.76M
Short-Term Investments	172.78K	172.38K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	1.1M	1.14M	502.68K	413.07K	272.63K	233.57K	67.02K	50.22K	17.24K	553.25K	45.04K	36.98K	103.68K	33.36K	59.27K	155.78K	96.44K	208.4K	149.69K	110.15K
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Non-Current Assets	53.01K	72.33K	92.18K	111.97K	128.98K	154.51K	176.99K	117.66K	12.07K	30.19K	48.3K	66.41K	84.53K	102.64K	120.75K	138.86K	2K	2K	2K	2K
Property, Plant & Equipment	53.01K	72.33K	92.18K	111.97K	128.98K	154.51K	176.99K	117.66K	12.07K	30.19K	48.3K	66.41K	84.53K	102.64K	120.75K	138.86K	0	0	0	0
Fixed Asset Turnover	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2K	2K	2K	2K
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.68K	33.68K
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-33.68K	-33.68K
Total Assets	310.84M	312.15M	90.88M	84.42M	52.5M	56.47M	58.4M	6.1M	6.28M	6.53M	6.89M	6.88M	8.46M	9.99M	11.55M	12.09M	8.82M	11.76M	15.41M	20.04M
Asset Turnover	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset Growth %	492.11%	452.77%	55.62%	1282.92%	736.23%	764.61%	747.95%	-11.26%	-25.8%	-34.6%	-40.37%	-43.09%	-4.07%	-15.1%	-25.06%	-39.69%	-60.3%	-54.3%	605.7%	2176.76%
Total Current Liabilities	2.55M	3.83M	1.58M	2.34M	604.99K	637.97K	461.52K	528.68K	178.63K	845.79K	854.16K	280.86K	720.8K	1.01M	528.1K	1.47M	385.32K	1M	489.6K	638.57K
Accounts Payable	2.36M	3.63M	1.43M	1.71M	510.8K	551.22K	373.63K	407.55K	149.61K	801.05K	799.6K	182.31K	643.4K	247.95K	322.17K	1.25M	385.32K	994.82K	482.6K	596.57K
Days Payables Outstanding	13.66K	11.31K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	117.93K	-2.69K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Ratio	121.97x	81.48x	57.37x	36.10x	86.56x	88.27x	126.15x	11.32x	35.08x	7.69x	8.01x	24.26x	11.62x	9.83x	21.64x	8.11x	22.88x	11.72x	31.48x	31.38x
Quick Ratio	121.97x	81.48x	57.37x	36.10x	86.56x	88.27x	126.15x	11.32x	35.08x	7.69x	8.01x	24.26x	11.62x	9.83x	21.64x	8.11x	22.88x	11.72x	31.48x	31.38x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	127	0	16.74K	41.25K	62.84K	88.85K	110.07K	39.58K	0	0	0	0	14.02K	34.73K	54.56K	71.98K	0	0	0	0
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	16.74K	41.25K	62.84K	88.85K	110.07K	39.58K	0	0	0	0	14.02K	34.73K	54.56K	71.98K	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Liabilities	2.55M	3.83M	1.6M	2.38M	667.83K	726.81K	571.59K	568.26K	178.63K	845.79K	854.16K	280.86K	734.81K	1.04M	582.66K	1.54M	385.32K	1M	489.6K	638.57K
Total Debt	65.7K	82.07K	104.9K	125.78K	141.03K	166.6K	182.73K	118.96K	14.02K	34.73K	54.56K	73.55K	91.41K	108.32K	124.48K	139.91K	0	0	0	0
Net Debt	-308.09M	-309.22M	-88.94M	-82.78M	-51.25M	-55.51M	-57.71M	-5.6M	-6.18M	-5.9M	-6.71M	-6.67M	-8.04M	-9.56M	-11.09M	-11.49M	-8.64M	-11.47M	-15.12M	-19.76M
Debt / Equity	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.02x	0.00x	0.01x	0.01x	0.01x	0.01x	0.01x	0.01x	0.01x	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	0.06x	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-24.43x	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-2811.00x	-1900.64x	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Equity	308.3M	308.32M	89.28M	82.04M	51.83M	55.74M	57.83M	5.54M	6.1M	5.69M	6.03M	6.6M	7.73M	8.95M	10.97M	10.54M	8.43M	10.76M	14.92M	19.4M
Equity Growth %	494.82%	453.11%	54.39%	1381.93%	749.77%	880.45%	858.53%	-16.09%	-21.05%	-36.45%	-44.99%	-37.41%	-8.4%	-16.85%	-26.51%	-45.66%	-61.47%	-57.52%	614.49%	2560.36%
Book Value per Share	31.36	32.15	11.50	11.45	7.32	11.99	12.44	1.19	1.31	1.27	1.57	1.75	2.05	2.36	3.06	3.53	3.55	4.54	6.30	8.20
Total Shareholders' Equity	308.3M	308.32M	89.28M	82.04M	51.83M	55.74M	57.83M	5.54M	6.1M	5.69M	6.03M	6.6M	7.73M	8.95M	10.97M	10.54M	8.43M	10.76M	14.92M	19.4M
Common Stock	366.58M	365.52M	136.77M	123.25M	89.91M	89.89M	89.02M	35.42M	35.05M	35.05M	35.05M	33.91M	33.91M	33.91M	33.68M	32.24M	27.19M	27.17M	27.18M	27.08M
Retained Earnings	-67.11M	-64.56M	-54.14M	-46.58M	-42.49M	-37.25M	-34.3M	-34.35M	-33.58M	-33.81M	-33.23M	-31.55M	-30.02M	-28.56M	-26.51M	-24.17M	-21.21M	-18.56M	-14.07M	-9.21M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	8.83M	7.35M	6.65M	5.37M	4.41M	3.1M	3.11M	4.01M	3.8M	3.61M	3.39M	3.4M	3M	2.76M	2.96M	2.48M	2.45M	2.15M	1.85M	1.57M
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0